Cargando…
Developing New Therapies for Delta Hepatitis: The Race Is On
Autores principales: | Gençdal, Genco, Yurdaydin, Cihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034575/ https://www.ncbi.nlm.nih.gov/pubmed/33860114 http://dx.doi.org/10.1002/hep4.1685 |
Ejemplares similares
-
The course of COVID-19 infection in patients with chronic hepatitis B and Delta
por: Parlar, Yavuz Emre, et al.
Publicado: (2022) -
Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
por: Abayli, Bahri, et al.
Publicado: (2021) -
Recent advances in managing hepatitis D
por: Yurdaydin, Cihan
Publicado: (2017) -
A Rapid Point-of-Care Test for the Serodiagnosis of Hepatitis Delta Virus Infection
por: Lempp, Florian A., et al.
Publicado: (2021) -
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta
por: Sandmann, Lisa, et al.
Publicado: (2021)